Improved Cognitive Performance and Reduced Monocyte Activation in Virally Suppressed Chronic HIV After Dual CCR2 and CCR5 Antagonism.

D'Antoni ML, Paul RH, Mitchell BI, Kohorn L, Fischer L, Lefebvre E, Seyedkazemi S, Nakamoto BK, Walker M, Kallianpur KJ, Ogata-Arakaki D, Ndhlovu LC, Shikuma C. Improved Cognitive Performance and Reduced Monocyte Activation in Virally Suppressed Chronic HIV After Dual CCR2 and CCR5 Antagonism. J Acquir Immune Defic Syndr. 2018 09 01; 79(1):108-116.

View in: PubMed

subject areas

Anti-HIV Agents
Cognition
Female
HIV Infections
Humans
Leukocyte Count
Macrophage Activation
Male
Middle Aged
Monocytes
Neuropsychological Tests
Pilot Projects
Receptors, CCR2
Receptors, CCR5
Viral Load

authors with profiles

Beau Nakamoto, MD
Lishomwa Ndhlovu, MD PhD
Brooks Mitchell, PhD
Cecilia M. Shikuma,MD
Kalpana Kallianpur, PhD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support